Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
22-2
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Abstracts
Classification
Classification #11.4
advertisement
11.4 Prostaglandins
(69)
Showing records 1 to 25
Display all abstracts in classification
11.4 Prostaglandins
Search within classification 11.4 Prostaglandins
94452
Headaches related to latanoprost in open-angle glaucoma
Wang H
Clinical and Experimental Optometry
2021; 104: 625-633
94922
Effect of Prostaglandin Analogues on Corneal Biomechanical Parameters Measured with a Dynamic Scheimpflug Analyzer
Yasukura Y
Journal of Glaucoma
2021; 30: 996-1000
94845
Efficacy and Safety of Preservative-free Latanoprost Eyedrops Compared with Preserved Prostaglandin Analogues in Patients with Open-angle Glaucoma
Seong HJ
Korean Journal of Ophthalmology
2021; 35: 235-241
94892
Effect of prostaglandin analogues on anterior scleral thickness and corneal thickness in patients with primary open-angle glaucoma
Park JH
Scientific reports
2021; 11: 11098
94303
Prostanoid receptor agonists for glaucoma treatment
Aihara M
Japanese Journal of Ophthalmology
2021; 65: 581-590
94535
The Additive Effect of ROCK Inhibitor on Prostaglandin-Treated Japanese Patients with Glaucoma Indicating 15 mmHg and Under: ROCK U-15
Sakata R
Advances in Therapy
2021; 38: 3760-3770
94927
Long-Term Effectiveness and Safety of Tafluprost, Travoprost, and Latanoprost in Korean Patients with Primary Open-Angle Glaucoma or Normal-Tension Glaucoma: A Multicenter Retrospective Cohort Study (LOTUS Study)
Kim JM
Journal of clinical medicine
2021; 10:
94617
Efficacy and tolerance of Latanoprost given as a first intention in the treatment of primitive open angle glaucoma in African melanoderm
Napo A
Journal Français d'Ophtalmologie
2021; 44: 1223-1228
94605
A Randomized Phase 2 Trial Comparing Omidenepag Isopropyl 0.002% Once and Twice Daily in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension (SPECTRUM-6)
Olander KW
Journal of Glaucoma
2021; 30: 473-480
94608
Recovery of deepening of the upper eyelid sulcus after switching from prostaglandin FP receptor agonists to EP2 receptor agonist: a 3-month prospective analysis
Sakata R
Japanese Journal of Ophthalmology
2021; 65: 591-597
94549
Differences in the eyelid and buccal microbiome of glaucoma patients receiving long-term administration of prostaglandin analog drops
Lim SH
Graefe's Archive for Clinical and Experimental Ophthalmology
2021; 259: 3055-3065
94535
The Additive Effect of ROCK Inhibitor on Prostaglandin-Treated Japanese Patients with Glaucoma Indicating 15 mmHg and Under: ROCK U-15
Fujishiro T
Advances in Therapy
2021; 38: 3760-3770
94452
Headaches related to latanoprost in open-angle glaucoma
Masselos K
Clinical and Experimental Optometry
2021; 104: 625-633
94922
Effect of Prostaglandin Analogues on Corneal Biomechanical Parameters Measured with a Dynamic Scheimpflug Analyzer
Miki A
Journal of Glaucoma
2021; 30: 996-1000
94927
Long-Term Effectiveness and Safety of Tafluprost, Travoprost, and Latanoprost in Korean Patients with Primary Open-Angle Glaucoma or Normal-Tension Glaucoma: A Multicenter Retrospective Cohort Study (LOTUS Study)
Sung KR
Journal of clinical medicine
2021; 10:
94892
Effect of prostaglandin analogues on anterior scleral thickness and corneal thickness in patients with primary open-angle glaucoma
Yoo C
Scientific reports
2021; 11: 11098
94608
Recovery of deepening of the upper eyelid sulcus after switching from prostaglandin FP receptor agonists to EP2 receptor agonist: a 3-month prospective analysis
Fujishiro T
Japanese Journal of Ophthalmology
2021; 65: 591-597
94549
Differences in the eyelid and buccal microbiome of glaucoma patients receiving long-term administration of prostaglandin analog drops
Shin JH
Graefe's Archive for Clinical and Experimental Ophthalmology
2021; 259: 3055-3065
94617
Efficacy and tolerance of Latanoprost given as a first intention in the treatment of primitive open angle glaucoma in African melanoderm
Aboubakar H
Journal Français d'Ophtalmologie
2021; 44: 1223-1228
94605
A Randomized Phase 2 Trial Comparing Omidenepag Isopropyl 0.002% Once and Twice Daily in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension (SPECTRUM-6)
Sato MA
Journal of Glaucoma
2021; 30: 473-480
94845
Efficacy and Safety of Preservative-free Latanoprost Eyedrops Compared with Preserved Prostaglandin Analogues in Patients with Open-angle Glaucoma
Lee K
Korean Journal of Ophthalmology
2021; 35: 235-241
94892
Effect of prostaglandin analogues on anterior scleral thickness and corneal thickness in patients with primary open-angle glaucoma
Chung HW
Scientific reports
2021; 11: 11098
94922
Effect of Prostaglandin Analogues on Corneal Biomechanical Parameters Measured with a Dynamic Scheimpflug Analyzer
Maeda N
Journal of Glaucoma
2021; 30: 996-1000
94617
Efficacy and tolerance of Latanoprost given as a first intention in the treatment of primitive open angle glaucoma in African melanoderm
Sidibe M
Journal Français d'Ophtalmologie
2021; 44: 1223-1228
94608
Recovery of deepening of the upper eyelid sulcus after switching from prostaglandin FP receptor agonists to EP2 receptor agonist: a 3-month prospective analysis
Saito H
Japanese Journal of Ophthalmology
2021; 65: 591-597
«
1
2
3
»
Issue
22-2
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
24-1 (2024)
23-4 (2023)
23-3 (2023)
23-2 (2023)
23-1 (2022)
22-4 (2022)
22-3 (2022)
22-2 (2021)
22-1 (2021)
21-4 (2021)
21-3 (2021)
21-2 (2021)
21-1 (2020)
20-4 (2020)
20-3 (2020)
20-2 (2019)
20-1 (2019)
19-4 (2019)
19-3 (2018)
19-2 (2018)
19-1 (2018)
18-4 (2017)
18-3 (2017)
18-2 (2017)
18-1 (2017)
17-4 (2016)
17-3 (2016)
17-2 (2016)
17-1 (2016)
16-4 (2015)
16-3 (2015)
16-2 (2015)
16-1 (2014)
15-4 (2014)
15-3 (2014)
15-2 (2013)
15-1 (2013)
14-4 (2013)
14-3 (2013)
14-2 (2013)
14-1 (2012)
13-4 (2012)
13-3 (2011)
13-2 (2011)
13-1 (2011)
12-4 (2011)
12-3 (2010)
12-2 (2010)
12-1 (2010)
11-4 (2010)
11-3 (2009)
11-2 (2009)
11-1 (2009)
10-4 (2009)
10-3 (2008)
10-2 (2008)
10-1 (2008)
9-4 (2008)
9-3 (2007)
9-2 (2007)
9-1 (2007)
8-4 (2007)
8-3 (2006)
8-2 (2006)
8-1 (2006)
7-3 (2006)
7-2 (2005)
7-1 (2005)
6-3 (2005)
6-2 (2004)
6-1 (2004)
5-3 (2004)
5-2 (2003)
5-1 (2003)
4-3 (2003)
4-2 (2002)
4-1 (2002)
3-3 (2002)
3-2 (2001)
3-1 (2001)
2-3 (2001)
2-2 (2000)
2-1 (2000)
1-3 (2000)
1-2 (1999)
1-1 (1999)
advertisement